Wave Life Sciences Ltd. ( WVE) - Key Metrics
WVE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.10 | -$0.30 | -$0.18 | -$0.18 |
| 2025Q3 | $0.05 | -$0.32 | -$0.27 | -$0.27 |
| 2025Q2 | $0.05 | -$0.31 | -$0.28 | -$0.28 |
| 2025Q1 | $0.06 | -$0.29 | -$0.39 | -$0.39 |
WVE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -14.40 |
| 2025Q3 | ? | -5.70 |
| 2025Q2 | ? | -5.28 |
| 2025Q1 | ? | -7.00 |
WVE
Price: $5.73
52 week price:
Earnings Per Share: -1.05 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Singapore
Volume: 358300
Ebitda: -26.4 millionMarket Capitalization: 1.2 billion